Connection
Elizabeth Redente to Erlotinib Hydrochloride
This is a "connection" page, showing publications Elizabeth Redente has written about Erlotinib Hydrochloride.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.018 |
|
|
|
-
Zerbe LK, Dwyer-Nield LD, Fritz JM, Redente EF, Shroyer RJ, Conklin E, Kane S, Tucker C, Eckhardt SG, Gustafson DL, Iwata KK, Malkinson AM. Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice. Cancer Chemother Pharmacol. 2008 Sep; 62(4):605-20.
Score: 0.018